ABOS
Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)
$59
About Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.
Details
Daily high
$2.64
Daily low
$2.56
Price at open
$2.63
52 Week High
$3.60
52 Week Low
$1.22
Market cap
191.6M
Dividend yield
-
Volume
395,179
Avg. volume
360,857
P/E ratio
-1.62
Acumen Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$2.64
Daily low
$2.56
Price at open
$2.63
52 Week High
$3.60
52 Week Low
$1.22
Market cap
191.6M
Dividend yield
-
Volume
395,179
Avg. volume
360,857
P/E ratio
-1.62